BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34465361)

  • 21. HSP90 and HSP70 proteins are essential for stabilization and activation of WASF3 metastasis-promoting protein.
    Teng Y; Ngoka L; Mei Y; Lesoon L; Cowell JK
    J Biol Chem; 2012 Mar; 287(13):10051-10059. PubMed ID: 22315230
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Nie Y; Hu S; Liu S; Fang N; Guo F; Yang L; Liang X
    Future Oncol; 2019 May; 15(14):1605-1615. PubMed ID: 31038356
    [No Abstract]   [Full Text] [Related]  

  • 23. Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases.
    Teng Y; Ren MQ; Cheney R; Sharma S; Cowell JK
    Br J Cancer; 2010 Sep; 103(7):1066-75. PubMed ID: 20717117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small molecule 1'-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1/STAT3/MMPs signaling pathway.
    Wang J; Zhang L; Chen G; Zhang J; Li Z; Lu W; Liu M; Pang X
    Breast Cancer Res Treat; 2014 Nov; 148(2):279-89. PubMed ID: 25301089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line.
    Bjorge JD; Pang AS; Funnell M; Chen KY; Diaz R; Magliocco AM; Fujita DJ
    PLoS One; 2011 Apr; 6(4):e19309. PubMed ID: 21541295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer.
    Pan YM; Wang CG; Zhu M; Xing R; Cui JT; Li WM; Yu DD; Wang SB; Zhu W; Ye YJ; Wu Y; Wang S; Lu YY
    Mol Cancer; 2016 Dec; 15(1):79. PubMed ID: 27938379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer.
    Huang P; Liao R; Chen X; Wu X; Li X; Wang Y; Cao Q; Dong C
    Theranostics; 2020; 10(10):4644-4658. PubMed ID: 32292520
    [No Abstract]   [Full Text] [Related]  

  • 28. MiR-375 suppresses invasion and metastasis by direct targeting of SHOX2 in esophageal squamous cell carcinoma.
    Yi J; Jin L; Chen J; Feng B; He Z; Chen L; Song H
    Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):159-169. PubMed ID: 28069583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells.
    Wang T; Yuan J; Zhang J; Tian R; Ji W; Zhou Y; Yang Y; Song W; Zhang F; Niu R
    Oncotarget; 2015 Oct; 6(31):30975-92. PubMed ID: 26307676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ZIC2 is downregulated and represses tumor growth via the regulation of STAT3 in breast cancer.
    Liu ZH; Chen ML; Zhang Q; Zhang Y; An X; Luo YL; Liu XM; Liu SX; Liu Q; Yang T; Liu YM; Liu BL; Zhou AJ; Li MZ; Liu YJ; Liu ZX; Zhong Q
    Int J Cancer; 2020 Jul; 147(2):505-518. PubMed ID: 32064600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion.
    Sethuraman A; Brown M; Krutilina R; Wu ZH; Seagroves TN; Pfeffer LM; Fan M
    Breast Cancer Res; 2018 Oct; 20(1):117. PubMed ID: 30285805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing of Prrx2 Inhibits the Invasion and Metastasis of Breast Cancer both In Vitro and In Vivo by Reversing Epithelial-Mesenchymal Transition.
    Lv ZD; Wang HB; Liu XP; Jin LY; Shen RW; Wang XG; Kong B; Qu HL; Li FN; Yang QF
    Cell Physiol Biochem; 2017; 42(5):1847-1856. PubMed ID: 28750408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.
    Zhao D; Besser AH; Wander SA; Sun J; Zhou W; Wang B; Ince T; Durante MA; Guo W; Mills G; Theodorescu D; Slingerland J
    Oncogene; 2015 Oct; 34(43):5447-59. PubMed ID: 25684140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lycorine inhibits the growth and metastasis of breast cancer through the blockage of STAT3 signaling pathway.
    Wang J; Xu J; Xing G
    Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):771-779. PubMed ID: 28910973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tex10 interacts with STAT3 to regulate hepatocellular carcinoma growth and metastasis.
    Xiang X; Kuang W; Yu C; Li Y; Su Q; Tian Y; Li J
    Mol Carcinog; 2023 Dec; 62(12):1974-1989. PubMed ID: 37792308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The involvement of JAK-STAT3 in cell motility, invasion, and metastasis.
    Teng Y; Ross JL; Cowell JK
    JAKSTAT; 2014 Jan; 3(1):e28086. PubMed ID: 24778926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition.
    Guo L; Chen C; Shi M; Wang F; Chen X; Diao D; Hu M; Yu M; Qian L; Guo N
    Oncogene; 2013 Nov; 32(45):5272-82. PubMed ID: 23318420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA PVT1 induces aggressive vasculogenic mimicry formation through activating the STAT3/Slug axis and epithelial-to-mesenchymal transition in gastric cancer.
    Zhao J; Wu J; Qin Y; Zhang W; Huang G; Qin L
    Cell Oncol (Dordr); 2020 Oct; 43(5):863-876. PubMed ID: 32729021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis.
    Huang L; Hu B; Ni J; Wu J; Jiang W; Chen C; Yang L; Zeng Y; Wan R; Hu G; Wang X
    J Exp Clin Cancer Res; 2016 Feb; 35():27. PubMed ID: 26847351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An E2F1-HOXB9 transcriptional circuit is associated with breast cancer progression.
    Zhussupova A; Hayashida T; Takahashi M; Miyao K; Okazaki H; Jinno H; Kitagawa Y
    PLoS One; 2014; 9(8):e105285. PubMed ID: 25136922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.